These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neutralization of extrapyramidal side-effects with Methixene. Maller O; Heller S Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695 [No Abstract] [Full Text] [Related]
3. Neurological syndromes associated with antipsychotic drug use. A special report. Freedman DX Arch Gen Psychiatry; 1973 Apr; 28(4):463-7. PubMed ID: 4692143 [No Abstract] [Full Text] [Related]
4. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment]. Deniker P; Ginestet D Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195 [No Abstract] [Full Text] [Related]
5. [Extra-pyramidal syndrome caused by neuroleptics]. Lambert PA Encephale; 1973; 62(1):78-105. PubMed ID: 4718697 [No Abstract] [Full Text] [Related]
7. [Somatic disorders during long-term drug treatment of schizophrenic patients]. vom Brocke I Internist (Berl); 1974 May; 15(5):268-70. PubMed ID: 4213663 [No Abstract] [Full Text] [Related]
8. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs]. Vatsek Ia Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940 [No Abstract] [Full Text] [Related]
9. [Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics]. Berchtold P; Hinssen M; Irmscher K Dtsch Med Wochenschr; 1974 Mar; 99(9):420-1. PubMed ID: 4151333 [No Abstract] [Full Text] [Related]
11. [Incidents and accidents during therapy with long-acting neuroleptics]. Escande M; Vasquez Villareal S; Gayral L Ann Med Psychol (Paris); 1974 Jan; 1(1):112-20. PubMed ID: 4210849 [No Abstract] [Full Text] [Related]
12. Drug-induced Parkinson-like syndrome. Va Med Mon (1918); 1968 Dec; 95(12):746-50 passim. PubMed ID: 5725399 [No Abstract] [Full Text] [Related]
13. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome]. Kamianov IM; Kupisk AG; Katsen IZ Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581 [No Abstract] [Full Text] [Related]
14. Clinical experience with fluspirilene in psychoses. Svestka J; Náhunek K; Hádlík J; Rodová A Act Nerv Super (Praha); 1971; 13(3):173-4. PubMed ID: 5113825 [No Abstract] [Full Text] [Related]
16. [Neurologic and psychic complications in treatment with neuroleptics]. Gerlach J Ugeskr Laeger; 1976 Jun; 138(27):1650-3. PubMed ID: 951778 [No Abstract] [Full Text] [Related]
17. Prevention and management of tardive dyskinesia. Crane GE Am J Psychiatry; 1972 Oct; 129(4):466-7. PubMed ID: 5071149 [No Abstract] [Full Text] [Related]
18. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)]. Bourgeois M; Bouey P Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864 [No Abstract] [Full Text] [Related]
19. The membrane actions of tranquilizers in relation to neuroleptic-induced parkinsonism and tardive dyskinesia. Seeman P; Staiman A; Lee T; Chau-Wong M Adv Biochem Psychopharmacol; 1974; 9(0):137-48. PubMed ID: 4151919 [No Abstract] [Full Text] [Related]
20. [Chronic facio-lingual dyskinesia in patients treated with neuroleptics]. Gralewski Z Neurol Neurochir Pol; 1973; 7(3):393-8. PubMed ID: 4714195 [No Abstract] [Full Text] [Related] [Next] [New Search]